Raymond James & Associates Ark Genomic Revolution ETF (De Transaction History
Raymond James & Associates
- $161 Billion
- Q3 2024
A detailed history of Raymond James & Associates transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Raymond James & Associates holds 60,535 shares of ARKG stock, worth $1.63 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
60,535
Previous 82,411
26.55%
Holding current value
$1.63 Million
Previous $1.94 Million
19.95%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding ARKG
# of Institutions
296Shares Held
20.4MCall Options Held
2.53MPut Options Held
2.8M-
Jpmorgan Chase & CO New York, NY3.94MShares$106 Million0.01% of portfolio
-
Morgan Stanley New York, NY2.83MShares$76.2 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY2.16MShares$58.1 Million0.01% of portfolio
-
Citigroup Inc1.52MShares$40.8 Million0.02% of portfolio
-
Ubs Group Ag1.12MShares$30.1 Million0.01% of portfolio